Bone marrow–derived stem cells preserve cone vision in retinitis pigmentosa
AUTOR(ES)
Smith, Lois E.H.
FONTE
American Society for Clinical Investigation
RESUMO
Retinitis pigmentosa is a heritable group of blinding diseases resulting from loss of photoreceptors, primarily rods and secondarily cones, that mediate central vision. Loss of retinal vasculature is a presumed metabolic consequence of photoreceptor degeneration. A new study shows that autologous bone marrow–derived lineage-negative hematopoietic stem cells, which incorporate into the degenerating blood vessels in two murine models of retinitis pigmentosa, rd1 and rd10, prevent cone loss. The use of autologous bone marrow might avoid problems with rejection while preserving central cone vision in a wide variety of genetically disparate retinal degenerative diseases.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=516270Documentos Relacionados
- Bone marrow–derived progenitor cells in pulmonary fibrosis
- Ratio of blood and marrow-derived cells in bone marrow transplantation.
- Bone Marrow-Derived Cathepsin K Cleaves SPARC in Bone Metastasis
- Rescue of retinal degeneration by intravitreally injected adult bone marrow–derived lineage-negative hematopoietic stem cells
- Selective resistance of bone marrow-derived hemopoietic progenitor cells to gliotoxin.